litlas
Log inCreate account

Keith L. Knutson

Active 1997–2024

80
Papers
18,312
Citations
58
h-index
74
i10-index

Citations

Citations per year for Keith L. Knutson1997: 1 citations1998: 8 citations1999: 23 citations2000: 16 citations2001: 25 citations2002: 42 citations2003: 62 citations2004: 65 citations2005: 130 citations2006: 169 citations2007: 206 citations2008: 208 citations2009: 230 citations2010: 196 citations2011: 207 citations2012: 250 citations2013: 217 citations2014: 189 citations2015: 236 citations2016: 226 citations2017: 233 citations2018: 246 citations2019: 678 citations2020: 839 citations2021: 799 citations2022: 645 citations2023: 416 citations2024: 573 citations2025: 277 citations2026: 8 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,788 citing papers, 29.1% of this breakdownChina: 1,459 citing papers, 15.2% of this breakdownUnited Kingdom: 459 citing papers, 4.8% of this breakdownGermany: 451 citing papers, 4.7% of this breakdownFrance: 401 citing papers, 4.2% of this breakdownItaly: 397 citing papers, 4.1% of this breakdownJapan: 310 citing papers, 3.2% of this breakdownCanada: 275 citing papers, 2.9% of this breakdownAustralia: 229 citing papers, 2.4% of this breakdownNetherlands: 209 citing papers, 2.2% of this breakdownIndia: 193 citing papers, 2% of this breakdownSpain: 192 citing papers, 2% of this breakdown
0%29.1%Other 23.2%

Institutions

Fields

  • Medicine46.3%
  • Immunology and Microbiology32.9%
  • Biochemistry, Genetics and Molecular Biology16.3%
  • Engineering1.6%
  • Neuroscience0.9%
  • Materials Science0.7%
  • Other1.3%

Topics

  • Cancer Immunotherapy and Biomarkers12.2%
  • Immunotherapy and Immune Responses10.8%
  • Immune Cell Function and Interaction8.9%
  • Immune cells in cancer5.3%
  • T-cell and B-cell Immunology4.2%
  • CAR-T cell therapy research4.1%
  • Other54.5%

Coauthors

All papers

Open in search
  1. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

    Authors: Tyler J. Curiel, George Coukos, Linhua Zou, Xavier Álvarez, Pui Cheng, Peter Mottram, Melina Evdemon-Hogan, José R. Conejo-García, Lin Zhang, Matthew E. Burow, Yun Zhu, Shuang Wei, Ilona Kryczek, Ben Daniel, Alan N. Gordon, Leann Myers, Andrew A. Lackner, Mary L. Disis, Keith L. Knutson, Lieping Chen, Weiping Zou - Nature Medicine 2004 cited by 5,059

  2. Next generation of immune checkpoint therapy in cancer: new developments and challenges

    Authors: Julian A. Marin‐Acevedo, Bhagirathbhai Dholaria, Aixa Soyano, Keith L. Knutson, Saranya Chumsri, Yanyan Lou - Journal of Hematology & Oncology 2018 cited by 800

  3. The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant Disease

    Authors: Tina J. Hieken, Jun Chen, Tanya L. Hoskin, Marina Walther-António, Stephen Johnson, Sheri Ramaker, Jian Xiao, Derek C. Radisky, Keith L. Knutson, Krishna R. Kalari, Janet Yao, Larry M. Baddour, Nicholas Chia, Amy C. Degnim - Scientific Reports 2016 cited by 493

  4. Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

    Authors: Tyler J. Curiel, Shuang Wei, Haidong Dong, Xavier Álvarez, Pui Cheng, Peter Mottram, Roman Krzysiek, Keith L. Knutson, Ben Daniel, Maria Zimmermann, Odile David, Matthew E. Burow, Alan N. Gordon, Nina Dhurandhar, Leann Myers, Ruth Berggren, Akseli Hemminki, Ronald D. Alvarez, Dominique Émilie, David T. Curiel, Lieping Chen, Weiping Zou - Nature Medicine 2003 cited by 1,317

  5. Folate receptor alpha as a tumor target in epithelial ovarian cancer

    Authors: Kimberly R. Kalli, Ann L. Oberg, Gary L. Keeney, Teresa J. Christianson, Philip S. Low, Keith L. Knutson, Lynn C. Hartmann - Gynecologic Oncology 2008 cited by 467

  6. Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial

    Authors: Daniel V.T. Catenacci, Yoon‐Koo Kang, Haeseong Park, Hope E. Uronis, Keun-Wook Lee, Matthew Chau Hsien Ng, Peter C. Enzinger, Se Hoon Park, Philip J. Gold, Jill Lacy, Howard S. Höchster, Sang Cheul Oh, Yeul Hong Kim, Kristen A. Marrone, Ronan J. Kelly, Rosalyn A. Juergens, Jong Gwang Kim, Johanna C. Bendell, Thierry Alcindor, Sun Jin Sym, Eun‐Kee Song, Cheng Ean Chee, Yee Chao, Sunnie S. Y. Kim, A. Craig Lockhart, Keith L. Knutson, Jennifer Yen, Aleksandra Franovic, Jeffrey L. Nordstrom, Daner Li, Jon M. Wigginton, Jan Davidson‐Moncada, Minori Koshiji Rosales, Yung‐Jue Bang - The Lancet Oncology 2020 cited by 190

  7. Tumor-Infiltrating Dendritic Cells in Cancer Pathogenesis

    Authors: Jo Marie Tran Janco, Purushottam Lamichhane, Lavakumar Karyampudi, Keith L. Knutson - The Journal of Immunology 2015 cited by 422

  8. Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients

    Authors: Matthew S. Block, Allan B. Dietz, Michael P. Gustafson, Kimberly R. Kalli, Courtney L. Erskine, Bahaaeldin Youssef, Geraldine V. Vijay, Jacob B. Allred, Kevin D. Pavelko, Michael Strausbauch, Yi Lin, Megan E. Grudem, Aminah Jatoi, Carolyn M. Klampe, Andrea E. Wahner-Hendrickson, S. John Weroha, Gretchen Glaser, Amanika Kumar, Carrie Langstraat, Mary L. Solseth, Michael Deeds, Keith L. Knutson, Martin J. Cannon - Nature Communications 2020 cited by 88

  9. Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy

    Authors: Hengfeng Yuan, Wen Jiang, Christina A. Von Roemeling, Yaqing Qie, Xiujie Liu, Yuanxin Chen, Yifan Wang, Robert E. Wharen, Kyuson Yun, Guojun Bu, Keith L. Knutson, Betty Y.S. Kim - Nature Nanotechnology 2017 cited by 171

  10. Resistance to Trastuzumab

    Authors: Sneha Vivekanandhan, Keith L. Knutson - Cancers 2022 cited by 75

  11. Tumor-Infiltrating Programmed Death Receptor-1+ Dendritic Cells Mediate Immune Suppression in Ovarian Cancer

    Authors: James Krempski, Lavakumar Karyampudi, Marshall D. Behrens, Courtney L. Erskine, Lynn C. Hartmann, Haidong Dong, Ellen L. Goode, Kimberly R. Kalli, Keith L. Knutson - The Journal of Immunology 2011 cited by 246

  12. IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer

    Authors: Purushottam Lamichhane, Lavakumar Karyampudi, Barath Shreeder, James Krempski, Deborah Bahr, Joshua Daum, Kimberly R. Kalli, Ellen L. Goode, Matthew S. Block, Martin J. Cannon, Keith L. Knutson - Cancer Research 2017 cited by 167

  13. Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients

    Authors: Kimberly R. Kalli, Matthew S. Block, Pashtoon Murtaza Kasi, Courtney L. Erskine, Timothy J. Hobday, Allan B. Dietz, Douglas Padley, Michael P. Gustafson, Barath Shreeder, Danell Puglisi-Knutson, Dan W. Visscher, Toni K. Mangskau, G. Haswell Wilson, Keith L. Knutson - Clinical Cancer Research 2018 cited by 100

  14. Rheumatoid arthritis and cardiovascular disease

    Authors: Cynthia S. Crowson, Katherine P. Liao, John M. Davis, Daniel H. Solomon, Eric L. Matteson, Keith L. Knutson, Mark A. Hlatky, Sherine E. Gabriel - American Heart Journal 2013 cited by 354

  15. AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells

    Authors: Michael K. Asiedu, Francis Beauchamp‐Perez, James N. Ingle, Marshall D. Behrens, Derek C. Radisky, Keith L. Knutson - Oncogene 2013 cited by 293

  16. Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies

    Authors: Aixa Soyano, Bhagirathbhai Dholaria, Julian A. Marin‐Acevedo, Nancy N. Diehl, David O. Hodge, Yan Luo, Rami Manochakian, Saranya Chumsri, Alex A. Adjei, Keith L. Knutson, Yanyan Lou - Journal for ImmunoTherapy of Cancer 2018 cited by 157

  17. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy

    Authors: Keith L. Knutson, Mary L. Disis - Cancer Immunology Immunotherapy 2005 cited by 676

  18. Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial

    Authors: Dmitriy Zamarin, Sven Walderich, Aliya Holland, Qin Zhou, Alexia Iasonos, Jean Torrisi, Taha Merghoub, Lewis Chesebrough, Autumn S Mcdonnell, Jacqueline M Gallagher, Yanyun Li, Travis J. Hollmann, Rachel N. Grisham, Courtney L. Erskine, M.S. Block, Keith L. Knutson, Roisin E. O’Cearbhaill, Carol Aghajanian, Jason Konner - Journal for ImmunoTherapy of Cancer 2020 cited by 54

  19. Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer

    Authors: Jodi M. Carter, Saranya Chumsri, Douglas Hinerfeld, Yaohua Ma, Xue Wang, David Zahrieh, David W. Hillman, Kathleen Tenner, Jennifer M. Kachergus, Heather Ann Brauer, Sarah Warren, David Henderson, Ji Shi, Yi Liu, Heikki Joensuu, Henrik Lindman, Roberto A. Leon‐Ferre, Judy C. Boughey, Minetta C. Liu, James N. Ingle, Krishna R. Kalari, Fergus J. Couch, Keith L. Knutson, Matthew P. Goetz, Edith A. Perez, E. Aubrey Thompson - Nature Communications 2023 cited by 44

  20. The Ratios of CD8+ T Cells to CD4+CD25+ FOXP3+ and FOXP3- T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer

    Authors: Claudia C. Preston, Matthew J. Maurer, Ann L. Oberg, Daniel W. Visscher, Kimberly R. Kalli, Lynn C. Hartmann, Ellen L. Goode, Keith L. Knutson - PLoS ONE 2013 cited by 210

  21. PD-1 Blunts the Function of Ovarian Tumor–Infiltrating Dendritic Cells by Inactivating NF-κB

    Authors: Lavakumar Karyampudi, Purushottam Lamichhane, James Krempski, Kimberly R. Kalli, Marshall D. Behrens, Doris M. Vargas, Lynn C. Hartmann, Jo Marie Tran Janco, Haidong Dong, Karen E. Hedin, Allan B. Dietz, Ellen L. Goode, Keith L. Knutson - Cancer Research 2015 cited by 103

  22. Intraepithelial Effector (CD3+)/Regulatory (FoxP3+) T-Cell Ratio Predicts a Clinical Outcome of Human Colon Carcinoma

    Authors: Frank A. Sinicrope, Rafaela L. Rego, Stephen M. Ansell, Keith L. Knutson, Nathan R. Foster, Daniel J. Sargent - Gastroenterology 2009 cited by 328

  23. Cancer immunotherapy beyond immune checkpoint inhibitors

    Authors: Julian A. Marin‐Acevedo, Aixa Soyano, Bhagirathbhai Dholaria, Keith L. Knutson, Yanyan Lou - Journal of Hematology & Oncology 2018 cited by 209

  24. Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients

    Authors: Nadine Norton, Bahaaeldin Youssef, David W. Hillman, Aziza Nassar, Xochiquetzal J. Geiger, Brian M. Necela, Heshan Liu, Kathryn J. Ruddy, Mei‐Yin C. Polley, James N. Ingle, Fergus J. Couch, Edith A. Perez, Minetta C. Liu, Jodi M. Carter, Roberto A. Leon‐Ferre, Judy C. Boughey, Elizabeth B. Somers, Krishna R. Kalari, Daniel W. Visscher, Matthew P. Goetz, Keith L. Knutson - npj Breast Cancer 2020 cited by 72